To this end, we monitored changes in the formation of homotypic CIC structures between SDCSCs and parental CRC cells in the presence of immune cells or therapeutic antibodies (anti-EGFR antibody cetuximab or anti-PD-L1). This evidence concerns the gene EGFR and colorectal carcinoma.